Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues-Reference-Cited by-同舟云学术

Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues

Published:2013-08 Issue:4 Volume:14 Page:140-148
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Guaraldi G.,Zona S.,Cossarizza A.,Vernacotola L.,Carli F.,Lattanzi A.,Beghetto B.,Orlando G.,De Biasi S.,Termini R.,Garau M.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/hct1404-140

Reference24 articles.

1. Antiretroviral Treatment of Adult HIV Infection

2. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

3. Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety review of recommended, first-line single-tablet regimens in patients with HIV;Expert Opinion on Drug Safety;2021-05-27

2. Use of darunavir in HIV-1-infected individuals in routine clinical practice from 2012 to 2016 in France;Journal of Antimicrobial Chemotherapy;2019-08-05

3. Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era;Drug Design, Development and Therapy;2018-10

4. Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study;Atherosclerosis;2018-07

5. Darunavir for the treatment of HIV infection;Expert Opinion on Pharmacotherapy;2018-06-18